Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyuki Ujiie

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Journal of Dermatological Science|April 25, 2026
Identification of novel small molecule compounds with readthrough activity in Nagashima-type palmoplantar keratosisJin Teng Peh, Takato Sugiyama, Risa Nobuta, et al.
British Journal of Cancer|May 29, 2025
An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cellsChe-Yuan Hsu, Teruki Yanagi, Kodai Miyamoto, et al.
Journal of Dermatological Science|August 11, 2021
A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton's tyrosine kinase inhibitor, in pemphigusJun Yamagami, Hideyuki Ujiie, Yumi Aoyama, et al.
The Journal of Allergy and Clinical Immunology|June 9, 2025
Eosinophil-derived neurotoxin and eosinophil cationic protein are key molecules for blister formation in bullous pemphigoidTakamasa Ito, Ayame Kimura, Ken Muramatsu, et al.
JID Innovations : Skin Science From Molecules to Population Health|March 30, 2023
Native Autoantigen Complex Detects Pemphigoid AutoantibodiesShoko Mai, Kentaro Izumi, Yosuke Mai, et al.
The Journal of Allergy and Clinical Immunology|April 29, 2018
Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjectsKen Muramatsu, Hideyuki Ujiie, Ichiro Kobayashi, et al.
Rheumatology (Oxford, England)|December 2, 2022
Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot studyKeita Ninagawa, Masaru Kato, Satonori Tsuneta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 2009
A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodiesWataru Nishie, Daisuke Sawamura, Ken Natsuga, et al.
The Journal of Investigative Dermatology|March 5, 2019
Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9Shota Takashima, Satoru Shinkuma, Yasuyuki Fujita, et al.
The Journal of Investigative Dermatology|November 7, 2021
Wnt/β-Catenin Signaling Stabilizes Hemidesmosomes in KeratinocytesHideyuki Kosumi, Mika Watanabe, Satoru Shinkuma, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Journal of Dermatological Science|April 25, 2026
Identification of novel small molecule compounds with readthrough activity in Nagashima-type palmoplantar keratosisJin Teng Peh, Takato Sugiyama, Risa Nobuta, et al.
British Journal of Cancer|May 29, 2025
An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cellsChe-Yuan Hsu, Teruki Yanagi, Kodai Miyamoto, et al.
Journal of Dermatological Science|August 11, 2021
A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton's tyrosine kinase inhibitor, in pemphigusJun Yamagami, Hideyuki Ujiie, Yumi Aoyama, et al.
The Journal of Allergy and Clinical Immunology|June 9, 2025
Eosinophil-derived neurotoxin and eosinophil cationic protein are key molecules for blister formation in bullous pemphigoidTakamasa Ito, Ayame Kimura, Ken Muramatsu, et al.
JID Innovations : Skin Science From Molecules to Population Health|March 30, 2023
Native Autoantigen Complex Detects Pemphigoid AutoantibodiesShoko Mai, Kentaro Izumi, Yosuke Mai, et al.
The Journal of Allergy and Clinical Immunology|April 29, 2018
Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjectsKen Muramatsu, Hideyuki Ujiie, Ichiro Kobayashi, et al.
Rheumatology (Oxford, England)|December 2, 2022
Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot studyKeita Ninagawa, Masaru Kato, Satonori Tsuneta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 2009
A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodiesWataru Nishie, Daisuke Sawamura, Ken Natsuga, et al.
The Journal of Investigative Dermatology|March 5, 2019
Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9Shota Takashima, Satoru Shinkuma, Yasuyuki Fujita, et al.
The Journal of Investigative Dermatology|November 7, 2021
Wnt/β-Catenin Signaling Stabilizes Hemidesmosomes in KeratinocytesHideyuki Kosumi, Mika Watanabe, Satoru Shinkuma, et al.
Pageof 11